tirzepatide neuroprotection shows neuroprotective effects via... : Peptides Megan North MSN, APRN, NP-C

Schedule a consult with Dr D

Tirzepatide is the newer, more powerful option, a dual-action GLP-1/GIP receptor agonist that produces weight loss numbers researchers have never seen from any other medication

Combined with improved cardiovascular fitness, reduced inflammation, better body image, and stabilized neurochemistry, the picture at six months is often vastly different from the picture at six weeks

If a person experiences any of the following serious side effects, they should contact a doctor or pharmacy immediately: Severe headache Difficulty breathing Increased blood pressure Activation of mania or hypomania Raised blood cholesterol Nausea Brain fog Cough Chest pain Blurred vision Seizures Hallucinations Nosebleeds Weakness Difficulty concentrating Falling Tremors Suicidal thoughts Fainting Fever Confusion Vomiting Increased risk of bleeding Difficulty with coordination Patients should seek medical attention if the side effects worsen or display for prolonged periods

Side effects at this level are generally mild

Clinical Access & Oversight Excellent Monthly async check-ins